Cargando…
Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]
INTRODUCTION: PROWESS (Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis) was a phase III, randomized, double blind, placebo controlled, multicenter trial conducted in patients with severe sepsis from 164 medical centers. Here we report data collected at study entry for 169...
Autores principales: | Kinasewitz, Gary T, Yan, S Betty, Basson, Bruce, Comp, Philip, Russell, James A, Cariou, Alain, Um, Suzane L, Utterback, Barbara, Laterre, Pierre-Francois, Dhainaut, Jean-François |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC420030/ https://www.ncbi.nlm.nih.gov/pubmed/15025782 |
Ejemplares similares
-
The role of endothelial shear stress on haemodynamics, inflammation, coagulation and glycocalyx during sepsis
por: Lupu, Florea, et al.
Publicado: (2020) -
Re-establishing organ function in severe sepsis: targeting the microcirculation
por: Dhainaut, Jean-François
Publicado: (2005) -
Diagnosis and treatment of severe sepsis
por: Claessens, Yann-Erick, et al.
Publicado: (2007) -
Sex or no sex: Evolutionary adaptation occurs regardless
por: Seidl, Michael F, et al.
Publicado: (2014) -
Role of clinical evaluation committees in sepsis trials: from 'valid cohort' assessment to subgroup analysis
por: Dhainaut, Jean-François
Publicado: (2009)